Key result
Corin overexpression reduces myocardial infarct size by an absolute ~19% post-MI.
Why the study?
Altered corin expression is linked to dilated and ischemic cardiomyopathy, but its potential role in myocardial infarction is lacking.
Does cardiac corin overexpression reduce infarct size and improve heart function in a mouse model of myocardial infarction?
Does cardiac corin overexpression reduce infarct size and improve heart function in a mouse model of myocardial infarction?
Cardiac corin overexpression reduces apoptosis and infarct size while improving heart function post-MI in a mouse model, suggesting it as a potential therapeutic target for ischemic injury and remodeling.
Corin overexpression attenuated murine post-MI injury; hypothesis-generating and requires human studies before any clinical consideration.
Altered expression of corin, a cardiac transmembrane serine protease, has been linked to dilated and ischemic cardiomyopathy. However, the potential role of corin in myocardial infarction (MI) is lacking. This study examined the outcomes of MI in wild-type vs. cardiac-specific overexpressed corin transgenic (Corin-Tg) mice during pre-MI, early phase (3, 24, 72 h), and late phase (1, 4 weeks) post-MI. Corin overexpression significantly reduced cardiac cell apoptosis (p < 0.001), infarct size (p < 0.001), and inhibited cleavage of procaspases 3, 9, and 8 (p < 0.05 to p < 0.01), as well as altered the expression of Bcl2 family proteins, Bcl-xl, Bcl2 and Bak (p < 0.05 to p < 0.001) at 24 h post-MI. Overexpressed cardiac corin also significantly modulated heart function (ejection fraction, p < 0.0001), lung congestion (lung weight to body weight ratio, p < 0.0001), and systemic extracellular water (edema, p < 0.05) during late phase post-MI. Overall, cardiac corin overexpression significantly reduced apoptosis, infarct size, and modulated cardiac expression of key members of the apoptotic pathway in early phase post-MI; and led to significant improvement in heart function and reduced congestion in late phase post-MI. These findings suggest that corin may be a useful target to protect the heart from ischemic injury and subsequent post-infarction remodeling.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2020) studied Myocardial Infarction. Cardiac-specific corin overexpression (Corin-Tg) vs. Wild-type (WT) littermates was evaluated on Infarct area as a percentage of left ventricular area (IFA/LVA) at 24 hours post-MI (ARR 18.9% (43% relative reduction), p=<0.01). Cardiac-specific corin overexpression reduced myocardial infarct size by 43% (24.8% vs. 43.7% of LV area, p<0.01) and cardiomyocyte apoptosis by 60% (6.7% vs. 16.6%, p<0.001) at 24 hours post-MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: